Stereotaxis Procedure Prominently Featured on BBC Documentary 'From the Heart'

Stereotaxis Procedure Prominently Featured on BBC Documentary 'From the Heart'

ST. LOUIS, Feb. 17 /PRNewswire-FirstCall/ -- Stereotaxis (NASDAQ:STXS) announced that the recent BBC documentary "From the Heart" included a cardiac ablation procedure performed with the Stereotaxis System by Dr. Muchtiar Khan of OLVG Hospital in Amsterdam. The program's second half, beginning at 10:30 of the 25-minute run time, features extensive scenes from the Stereotaxis procedure. The documentary highlights how treatment of complex left atrial arrhythmias can reduce the growing prevalence of stroke. The documentary portrays Stereotaxis as an effective alternative to anti-arrhythmic drugs, and includes a visually compelling demonstration of the system's precise control of a magnetic catheter. The documentary is available at http://bit.ly/9e3C5P.

According to the documentary, fifteen percent of strokes are caused by atrial fibrillation, which affects over 6 million people world-wide and will increase approximately 2.5-fold by the year 2050. The program emphasizes how tens of thousands of people can be saved from stroke by identifying and treating patients with arrhythmia.

The Stereotaxis system allows the physician to control the tip of the catheter by using magnetic fields, providing reduced radiation exposure, a low major adverse event rate and clinical results which mimic the best hands in the world.

For more information on Stereotaxis, please visit www.stereotaxis.com.

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. Stereotaxis' Odyssey workstation integrates and standardizes data through a consolidated display of multiple systems, eliminating the challenge of interacting simultaneously with many separate diagnostic systems. The magnetic irrigated catheter is not approved for the treatment of atrial fibrillation in the US. The core components of the Stereotaxis system have received regulatory clearance in the U.S., Europe and Canada.

Source: Stereotaxis

CONTACT: Company, Dan Johnston, Chief Financial Officer of Stereotaxis,
+1-314-678-6007; or Investors, Doug Sherk & Jenifer Kirtland, +1-415-896-6820,
or Media, Steve DiMattia, +1-646-201-5445, all of EVC Group, Inc., for
Stereotaxis

Web Site: http://www.stereotaxis.com/

-------
Profile: intent